Germline mutations in the E-cadherin gene (CDH1) confer a high lifetime risk of developing hereditary diffuse gastric cancer (HDGC)
syndrome [
[1]
]. Classically, lobular breast cancer (LBC) has been described as a secondary “component”
of this syndrome [
[2]
]. However, recent studies have demonstrated that LBC is associated with germline
CDH1 mutations also in the absence of a family history of gastric cancer (GC). Some of
these germline mutations have been identified for the first time in LBC cases, others
were previously reported in individuals diagnosed with GC [
[3]
,
[4]
].Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Surgical OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Familial gastric cancer: overview and guidelines for management.J Med Genet. 1999; 36: 873-880
- Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation.Am J Pathol. 1999; 155: 337-342
- CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.J Med Genet. 2013; 50: 486-489
- Germline CDH1 mutations in bilateral lobular carcinoma in situ.Br J Canc. 2014; 110: 1053-1057
- E-cadherin germline mutation carriers: clinical management and genetic implications.Cancer Metastasis Rev. 2014; 33: 1081-1094
- Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.J Med Genet. 2018; 55: 431-441
- Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.J Med Genet. 2015; 52: 361-374
- CDH1 mutation screen in a BRCA1/2-negative familial breast-/ovarian cancer cohort.Arch Gynecol Obstet. 2018; 297: 147-152
- Panel testing reveals nonsense and missense CDH1 mutations in families without hereditary diffuse gastric cancer.Mol Genet Genomic Med. 2016; 4: 232-236
Article info
Publication history
Published online: July 19, 2019
Accepted:
July 16,
2019
Received in revised form:
July 8,
2019
Received:
June 17,
2019
Identification
Copyright
© 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
